← Eichor
Study identifier: NCT07463508 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Evaluation of Bile Acid Concentrations and Their Signaling as Markers of Testicular Tumorigenesis and Germ Cell Tumor Chemosensitivity

Condition: Testicular Germ Cell Cancer  ·  Sponsor: University Hospital, Clermont-Ferrand

PhaseNA
Planned participants20
Who can joinMale, 18 Years to no upper limit
Healthy volunteersNo

About this study

This is a study exploring measurable markers in the blood of patients with testicular tumors. The investigators will focus on the importance of measuring and analyzing these markers for their prognostic value and predictive response to treatment.

This description comes directly from the study's public registry record.

Talk to the study team

Lise LACLAUTRE  ·  0473754963  ·  promo_interne_drci@chu-clermontferrand.fr

Always discuss trial participation with your own doctor first.

Locations (1)

CHU Clermont-FerrandClermont-Ferrand, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07463508